ACNU-cisplatin continuous infusion chemotherapy as salvage therapy for recurrent glioblastomas: Phase II study

Journal of Neuro-Oncology

Volumn 75, Issue 2, 2005, Pages 173-180

  Gwak, Ho Shin ^a   Youn, Sang Min ^a   Kwon, Austin Hyuk ^a   Lee, Seung Hoon ^b   Kim, Jong Hyun ^c   Rhee, Chang Hun ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b National Cancer Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

ACNU; Chemotherapy; Cisplatin; Glioblastoma; Recurrent

Indexed keywords

ANTIBIOTIC AGENT; CISPLATIN; NIMUSTINE; ONDANSETRON; OSMOTIC AGENT; STEROID;

ADULT; ANEMIA; ANOREXIA; ARTICLE; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; BRAIN HEMORRHAGE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; GLIOBLASTOMA; HUMAN; HYPOMAGNESEMIA; INFECTION; LEUKOPENIA; LIVER DISEASE; MALE; METABOLIC DISORDER; NAUSEA; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OTOTOXICITY; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PNEUMONIA; PROGNOSIS; SALVAGE THERAPY; SEPSIS; SURVIVAL RATE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CISPLATIN; CLINICAL TRIALS, PHASE II; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GLIOBLASTOMA; HUMANS; KOREA; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NIMUSTINE; SALVAGE THERAPY; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 29244438142     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-1858-8     Document Type: Article

References (31)

1. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer O, Wismeth C, Klinkhammer-Schalke M, Allgauer M, Schuierer G, Koch H, Schlaier J, Ulrich W, Brawanski A, Bogdahn U, Steinbrecher A: Salvage therapy in patients with glioblastoma; Is there any benefit?. Cancer 98: 2678-2686, 2003
2. Dirks P, Berenstein M, Muller PJ, Tucker WS: The value of reoperation for recurrent glioblastoma. Can J Surg 36: 271-275, 1993
3. Barker FG II, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB: Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42: 709-723, 1998
4. Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD: Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms clinical study. Neurosurgery 41: 776-785, 1997
5. Alexander E III, Loeffler JS: Radiosurgery for primary malignant brain tumors. Semin Surg Oncol 14: 43-52, 1998
6. Paoletti P, Butti G, Gaetani KP, Assietti R: Chemotherapy for malignant gliomas of the brain: a review of ten-years experience. Acta Neurochir (Wien) 103: 35-46, 1990
7. Walker MD, Green SB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980
8. Kochii M, Kitamura I, Goto T, Nishi T, Takeshima H, Saito Y, Yamamoto K, Kimura T, Kino T, Tada K, Shiraishi S, Uemura S, Iwasaki T, Kuratsu J, Ushio Y: Randomized comparison of intraarterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma. J Neurooncol 49: 63-70, 2000
9. Iwadate Y, Namba H, Sueyoshi K: Intra-arterial ACNU and cisplatin chemotherapy for the treatment of glioblastoma multiforme. Neuol Med Chir (Tokyo) 35: 598-603, 1995
10. Hochberg FH, Parker LM, Takvorian T, Canellos GP, Zervas NT: High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg 54: 455-460, 1981
11. Witman G, Cadman E, Kapp D, Wagner F: The use of cisplatinum for treatment of malignant glioma. Med Hypotheses 335-341, 1982
12. Norman D, Stevens EA, Wings SD, Levin V, Newton TH: Quantitative aspects of contrast enhancement in cranial computed tomography. Neuroradiology 16: 549-551, 1978
13. Grossman SA, Sheidler VR, Ahn H et al.: Complete and partial responses of newly diagnosed malignant astrocytomas (MA) following continuous infusion BCNU and cisplatin. Proc Am Soc Clin Oncol 8: 344 (abstr)
14. Grossman SA, Wharam M, Sheidler V, Kleinberg L, Zeltzman M, Piantadosi S: Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma. J Clin Oncol 15: 2596-2603, 1997
15. Wakui A: Cancer chemotherapy with special reference to pharmacokinetics of nitrosoureas. Gan To Kagaku Ryoho 9: 1327-1338, 1982
16. Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozumi T, Matustani M, Nomura K: Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64: 53-57, 1986
17. Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42: 2474-2479, 1982
18. Stewart DJ, O'Bryan RM, Al-Sarraf M, Costanzi JJ, Oishi N: Phase II study of cisplatin in recurrent astrocytomas in adults: a southwest oncology group study. J Neurooncol 1: 145-147, 1983
19. Gerosa MA, Rosenblum ML, Stevanoni G, Lecata C, Corte VD, Marcon C, Bricolo A, Tridente G: In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas. Acta Neurol Scand 73: 66-70, 1986
20. Yung AWK, Janus TJ, Maor M, Feun LG: Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas. J Neurooncol 12: 131-135, 1992
21. Gilbert M, O'Neill A, Grossman S, Grunner M, Mehta M, Jubelirer S, Hellman R: A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group study (E2393). J Neurooncol 47: 145-152, 2000
22. Choi IS, Lee SH, Kim TY, Bang JS, Paek SH, Kim S, Kim IH, Heo DS, Bang YJ, Kim DG, Jung HW, Kim NK: Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme. J Neurooncol 60: 171-176, 2002
23. Kleinberg L, Grossman SA, Piantadosi S, Zeltman M, Wharam M: The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma. Int J Radiat Oncol Biol Phys 44: 535-543, 1999
24. Tsuboi K, Yoshii Y, Hyodo A, Takada K, Nose T: Leukoencepalopathy associated with intra-arterial ACNU in patients with gliomas. J Neurooncol 23: 223-231, 1995
25. Rosenblum MK, Delattre JY, Walker RW, Shapiro WR: Fatal necrotizing encepalopathy complicating treatment of malignant gliomas with intra-arterial BCNU and irradiation: a pathological study. J Neurooncol 11: 241-242, 1991
26. Qin DX, Zheng R, Tang J, Li JX, Hu YH: Influence of radiation on the blood-brain barrier and optimum time of chemotherapy. Int J Radiat Oncol Biol Phys 19: 1507-1510, 1990
27. Qin D, Ou G, Mo H, Song Y, Kang G, Hu Y, Gu X: Improved efficacy of chemotherapy for glioblastoma by radiation-induced opening of blood-brain barrier: clinical results. Int J Radiat Oncol Biol Phys 51: 959-962, 2001
28. Prados M, Rodriguez L, Chamberlain M, Silver P, Levin V: Treatment of recurrent gliomas with 1,3-bis(2-chlorethyl)-1-nitrosourea and alpha-difluoromethylornithine. Neurosurgery 24: 806-809, 1989
29. van den Bent MJ, Grisold W, Frappaz D, Stupp R, Desir JP, Lesimple T, Dittrich C, de Jonge MJA, Brandes A, Frenay M, Carpentier AF, Chollet P, Oliveira J, Baron B, Lacombe D, Schuessler M, Fumoleau P: European organization for research and treatment of cancer (EORTC) open label phase II study on glucosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme. Ann Oncol 14: 1732-1734, 2003
30. Brandes AA, Fiorentino MV: The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer Invest 14: 551-559, 1996
31. Silvani A, Eoli M, Salmaggi A, Erbetta A, Fariselli L, Boiardi A: Intra-arterial ACNU and carboplatin versus intravenous chemotherapy with cisplatin and BCNU in newly diagnosed patients with glioblastoma. Neurol Sci 23: 219-224, 2002